Ono Pharmaceutical Names New President
This article was originally published in PharmAsia News
Executive Summary
Osaka based Ono Pharmaceutical announced Aug. 5 that current VP Gyo Sagara will become president effective Sept. 1, and current president Daikichi Fukushima - who assumed the presidency July 27 - will become chairman. The company commented that Fukushima will lead a new global research strategy planning division and spend time on actively in-licensing new drug candidates from overseas for the company. With an inevitable increase in travel and less time for day-to-day management, the company decided to name Sagara as the new president. Sagara joined Ono in 1978 and became an executive director in 2007 and VP in February. (Click here for more - Japanese language) "Ono Pharmaceutical Names Gyo Sagara New President" - Yakuji News (8/6/08)
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.